维普中文期刊产品整合服务
19篇 您的检索式:作者名="Perey L"
    题名 作者 年代 出处 被引量
1Biotechnological intensification of biogas production显示文摘Zoltán Bagi Norbert ács Balázs Bálint Lenke Horváth Krisztina Dobó Katalin R. Perei Gábor Rákhely Kornél L. Kovács 2007Applied Microbiology and Biotechnology2007,,2:1
2Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors:final results of phase Ⅱ Swiss Group for Clinical Cancer Research Trial显示文摘Perey L Paridaens R Hawle H 2007Ann Oncol2007,18,1:1
3Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen显示文摘Perey L Hayes DF Maimonis P 1992Cancer Res1992,52,10:1
4Biotechnological intensification of biogas production 显示文摘Bagi Z Acs N Balint B Horv6th L Dob6 K Perei K R6khely G Kovacs K 20074ppl Microbiol Biotechnol2007,76,2:1
5Tumor Selective Reactivity of a Monoclonal Antibody Prepared Against A Recombinant Peptide Derived From the DF3 Human Breast Carcinoma-associated Antigen显示文摘Perey L Hayes DF Maimonis P 1992Cancer Research1992,52,1:1
6Occlusion pressure and its ratio to maximum inspiratory pressure are useful predictorsfor successful extubation following T-piece weaning trial显示文摘Capdevila X L Perrigault P F Perey P J 1995Cheat1995,108,2:1
7Clinical benefit of fulvestrant in postmenopansal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors : final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00) 显示文摘Perey L Paridaens R Hawie H 2007Ann Oneol2007,18,1:1
8Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors:final results of phase Ⅱ Swiss Group for Clinical Cancer Research Trial显示文摘Perey L Paridaens R Hawle H 2007Ann Oncol2007,,18:1
9Apoptotic regulation in primitive precursors显示文摘Peters R Leyvraz S Perey L 1998Blood1998,92,6:1
10Biotechnological intensification ofbiogas production显示文摘Bagi Z Acs N Balint B Hovrath L Dobo K Perei K R Rakhely G Kovacs K L 2007Applied Microbiology and Biotechnology2007,76,:1
11Apoptotic regulation in primitive hematopoietic precursors 显示文摘PETERS R LEYVRAZ S PEREY L 1998Blood1998,92,:1
12Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase Ⅱ Swiss Group for Clinical Cancer Research Trial (SAKK 21/00) 显示文摘PEREY L PARIDAENS R HAWLE H 2007Ann Oncol2007,18,:1
13Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase Ⅱ Swiss Group for Clinical Cancer Research Trial显示文摘Perey L Paridaens R Hawle H 2006Ann Oncol2006,10,:1
14Apoptotic regulation in primitive hematopoietic precursors 显示文摘Peters R Leyvraz S Perey L 1998Blood1998,92,6:1
15Final results of the EBMT study of sequential high-dose ICE with circulating progenitor cells(CPC) in small cell lung cancer (SCLC) 显示文摘 Rosti G Lange A 1998Bone Marrow Transplants1998,22,13:1
16Repopulation with IgA-containing cells of bronchial and intestinal lamina propria after transfer of homologous Peyer's patches and bronchial lymphocytes显示文摘Rudzik O Claney R L Perey D Y 1975J Immunol1975,114,:1
17Apoptotic regulation in primitive hematopoietic precursors 显示文摘Peters R Leyvraz S Perey L 1998Blood1998,92,6:1
18Apoptotic regulation in primitive hematopoietic precursors显示文摘Peters R Leyvraz S Perey L 1998Blood1998,92,6:1
19Mutiple courses of high-dose ifosfamide, carboplatin, and etopside with peripheral-blood progenitor cell and filgrastim for small-cell lung caner:A feasibility by the European Group for blood and marrow transplantation显示文摘 Perey L Rosti G 1999J Clin Oncol1999,17,11:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费